VURAL, E. H. Et Al. 2024. Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?. Frontiers in Pharmacology , vol.15 .

VURAL, E. H., Kaskati, T., Vural, İ. M., ÖZALP, M. A., & GÜMÜŞEL, B., (2024). Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?. Frontiers in Pharmacology , vol.15.

VURAL, ELİF Et Al. "Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?," Frontiers in Pharmacology , vol.15, 2024

VURAL, ELİF H. Et Al. "Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?." Frontiers in Pharmacology , vol.15, 2024

VURAL, E. H. Et Al. (2024) . "Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?." Frontiers in Pharmacology , vol.15.

@article{article, author={ELİF HİLAL VURAL Et Al. }, title={Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?}, journal={Frontiers in Pharmacology}, year=2024}